Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Dania Bacardi"'
1
Akademický článek
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac
Autor: Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v: Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Externí odkaz: https://doaj.org/article/7fa9e2020e7f4dcf9cc2aaa835127a26
Zobrazit plný text záznamu
2
Alternatives to Animal Use in Risk Assessment of Mixtures
Autor: Arkadiusz K. Kuczaj, Julia Hoeng, Arantza Muriana, Ainhoa Alzualde, Dania Bacardi Fernandez, Manuel C. Peitsch, A. Wallace Hayes, Anita R. Iskandar
Publikováno v: International Journal of Toxicology. 39:165-172
Risk assessment of chemical mixtures has emerged as a focus of research efforts, but traditional toxicology testing in mammals is costly, time-consuming, and subject to ethical scrutiny in the context of recent trends to reduce reliance on animal tes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eac8a1785bda924aa62e691e654f70c
https://doi.org/10.1177/1091581820905088
Zobrazit plný text záznamu
3
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac
Autor: Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v: Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d8f30674428280765d87fac0d7321fb
https://pubmed.ncbi.nlm.nih.gov/30859088
Zobrazit plný text záznamu
4
Akademický článek
Alternatives to Animal Use in Risk Assessment of Mixtures.
Autor: Wallace Hayes, A., Muriana, Arantza, Alzualde, Ainhoa, Fernandez, Dania Bacardi, Iskandar, Anita, Peitsch, Manuel C., Kuczaj, Arkadiusz, Hoeng, Julia
Publikováno v: International Journal of Toxicology (Sage); Mar/Apr2020, Vol. 39 Issue 2, p165-172, 8p
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Preclinical safety testing of the Quimi-Hib(r) vaccine adjuvanted with aluminum phosphate during product development
Autor: Dania Bacardí, Karelia Cosme, Lizet Aldana, Nelson Merino, José Suárez, Omar Mosqueda, Dioslaida Urquiza, Juan Romero, Roberto Madrigal, Rubén Amaya, Lourdes Hernández
Publikováno v: Biotecnología Aplicada, Vol 30, Iss 2, Pp 118-124
Haemophilus influenzae type b (Hib) is a Gram-negative bacterium causing diseases such as meningitis, pneumonia, epiglottis, cellulitis, septicemia and arthritis, among others. Hib-caused meningitis / Hib meningitis is a very serious disease with a d
Externí odkaz: https://doaj.org/article/010cc45f54d04f42a98b97cc9dc5a049
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje